Insider Transactions Reported by 16 Insiders of Ambrx Biopharma Cayman, Inc.

Location
La Jolla, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Ambrx Biopharma Cayman, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $642,190,694 15 Sep 2023
HOPU Reunion Co Ltd 10%+ Owner $360,103,335 01 Jan 2023
Commodore Capital LP 10%+ Owner $330,035,790 23 Feb 2023
Darwin Global Management, Ltd. 10%+ Owner $305,952,424 27 Jun 2023
WuXi AppTec Co., Ltd. 10%+ Owner $270,570,986 01 Jan 2023
Edward Hu Director $11,236,674 01 Jan 2023
Paul Maier V Director $785,800 07 Jun 2023
Stephen C. Glover Director $785,800 18 May 2023
Kate Hermans Director $785,800 07 Jun 2023
Janet Loesberg Director $785,800 07 Jun 2023
Margaret Dalesandro Director $654,830 01 Sep 2023
Xiaowei Chang Director 07 Jun 2023
Andrew Aromando Chief Operating Officer 05 Jul 2023
Sonja Nelson Chief Financial Officer 05 Jul 2023
Katrin Rupalla Director 27 Jan 2023
Daniel J. O'Connor President and CEO, Director 05 Jul 2023

Recent Insider Transactions by Companies or Individuals for Ambrx Biopharma Cayman, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.